ReviewTherapeutic advances in medical oncology2025

Understanding and overcoming CDK4/6 inhibitor resistance in HR+/HER2- metastatic breast cancer: clinical and molecular perspectives.

Jessé Lopes da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.